Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 353

Fear and greed in markets: where to from here?

The past few weeks have been a time of unprecedented turmoil and volatility in global equity markets. Closer to home, the Australian equity market had its fastest 30% fall in the history of the Australian Securities Exchange, with only the 1987 crash coming close in terms of severity. It took a week longer during the 1987 crash to reach the 20% drawdown mark.

However, what has also taken the market by surprise has been the speed of recovery in prices. Since bottoming in late March, many companies have more than doubled in price in just two weeks, ahead of potential earnings downgrades.

Extreme volatility such as this is a sure sign of investor uncertainty and lack of conviction. Equity markets have always been forward-looking, with movement merely reflecting changes in future expected earnings of the companies, magnified by sentiment such as fear and greed.

Where are we now?

To assess where we are in the current equity market cycle, it is important to take stock of some of the economic realities.

Investors’ fears are well-warranted. Western economies have responded to the spread of COVID-19 by shutting down social events, venues and other gatherings, which has seen a vast number of casual staff being laid off. For most OECD countries, over 60% of their GDP lies in consumer spending, and a consumption-led recession will inevitably lead to a material rise in unemployment over the next three to six months.

On a positive note, because equity markets are forward-looking, if authorities are able to control the COVID-19 outbreak quickly, it would see many companies’ earnings bounce back reasonably quickly, particularly with the significant pending stimulus. Trillions of dollars around the world has been deployed to stimulate economies, much of that yet to be spent. Central banks have learned that during times of stress, keeping money flowing in the economy is paramount.

Based on the action plan announced by the Reserve Bank of Australia, the Federal Government and other regulatory bodies, we believe the stimulus plan is sufficient for the current environment. One key variable at this stage is how long we will be in lock-down before consumers can be allowed out to spend the stimulus provided.

Australia has continued to manage the outbreak of COVID-19 much better than most other countries. We attribute this to the early and decisive actions taken by State and Federal Governments to close borders and introduce mitigation strategies to slow the rate of contagion. This, along with world-leading COVID-19 testing, has ensured the epidemic has had a manageable impact on the hospital system.

The focus of investors and the broader population is now turning to when these measures can be relaxed given the extraordinary impact on the economy and Government finances. We expect the Government to take a cautious approach such that the current social distancing and work from home policies will likely, to a large extent, remain in place for some weeks, if not months, yet. However we are hopeful things will start to normalise by the start of the new financial year.

Portfolio positioning

As an active manager, we see current market conditions as ripe for opportunity to add to high quality portfolio stocks, while maintaining an overweight in quality defensive sectors such as healthcare. Stock specifically, the top 10 holdings in the Tribeca Alpha Plus fund have delivered exceptional returns since the crisis hit.

Fisher and Paykel has upgraded earnings twice, largely as a result of the surge in demand for its hospital respiratory products (which account for more than 60% of group revenue).

A2 milk has surprised the market with its resilience across its distribution platforms. Mothers in China flocked online to stock up on quality-branded infant formula and as a strong online player, A2 has been well placed to benefit. This will likely cement its brand in the offline Chinese consumer segment too.

Coles Group is another top holding which has seen significant improvement in its sales as consumers are moving to stock up their pantries. It has also meaningfully outperformed its peers, including Woolworths, which we don’t hold in our portfolio.

More recently, we have increased our holdings in a number of other high quality businesses, including AfterPay and Tyro, both of which have short-term earnings sensitivity to economic conditions.

Our investment thesis for such growth businesses has always been premised upon their future growth opportunity, and the strength and longevity of their respective business models. One quarter of weak earnings does not change our view, although we are regularly testing our assumptions based on current economic conditions and duration of the COVID-19 lockdown. We have little doubt that once the market stabilises, these two businesses will meaningfully outperform. Indeed, at the time this article is written, both stocks have more than doubled since lows reached at the end of March.

 

Jun Bei Liu is Portfolio Manager at Tribeca Investment Partners. The information in this article is provided for informational purposes only. Any opinions expressed in this material reflect our judgment at this date and should not be relied upon as the basis of your investment decisions.

 

5 Comments
Adam
April 29, 2020

I think its safe to say this virus will be present in most countries until a vaccine is found or perhaps something to take the edge off its severity. Either which way , as clever as we humans can be you don't just serve up a vaccine shot to seven billion people in a couple of weeks. Delivery will take months. In the meantime the world economy will spiral down. Usually I like to think of something positive to cap off something negative. Perhaps in time to come there will be a lot more humble people in the world. That can't be a bad thing?

Ken
April 23, 2020

The movement of the market swings and the magnitude on a daily basis are unpredictable which proves to me that nobody I repeat nobody has the faintest idea what will happen next and how long before the markets return to somewhere near normal. The so called experts agree on one thing , they disagree, if you get the drift. I have been in the market since 1963 and I disagree with myself. I believe if you think you can pick what is going to happen next at this moment, you're a fool or a liar, I mean that in a friendly way. The best of luck to you all.

Reader comment
April 19, 2020

Oh! For a crystal ball. They say if the US sneezes, the rest of the World gets a cold. The US has a lot more pain to go from both a health and financial perspective. Sharemarkets are predictive so tend to be ahead of the game except for black swan events. The bottom will occur shortly before the easing of social and business restrictions in the US. Trump is a maverick, risk taker and it is an election year so there is a real danger that easing will occur too early and a second wave results in the US.

Stephen
April 16, 2020

"One quarter of weak earnings does not change our view". Is that your "view"? There will be only one quarter of weak earnings? I would suggest there will be at least two quarters where earnings for many companies will be decimated or even non existent for a small minority and as to a normalising of conditions thereafter who really knows the rapidity or the extent of a recovery? Risk is being underestimated yet once again.
Analysts are widely using historical earnings estimates while many companies have explicitly withdrawn earnings guidance because they have no idea what they will be. I suspect that revisions to earnings will be large going forward.

Jan
April 15, 2020

Down, down, down ... up, up ... down, down ... as if we know where it's going next. Glad I'm not investing for people who rely on me.

 

Leave a Comment:

RELATED ARTICLES

Fear is good if you are not part of the herd

COVID-19 and the madness of crowds

Chris Cuffe on why private debt is a hidden gem

banner

Most viewed in recent weeks

Vale Graham Hand

It’s with heavy hearts that we announce Firstlinks’ co-founder and former Managing Editor, Graham Hand, has died aged 66. Graham was a legendary figure in the finance industry and here are three tributes to him.

Australian stocks will crush housing over the next decade, one year on

Last year, I wrote an article suggesting returns from ASX stocks would trample those from housing over the next decade. One year later, this is an update on how that forecast is going and what's changed since.

Avoiding wealth transfer pitfalls

Australia is in the early throes of an intergenerational wealth transfer worth an estimated $3.5 trillion. Here's a case study highlighting some of the challenges with transferring wealth between generations.

Taxpayers betrayed by Future Fund debacle

The Future Fund's original purpose was to meet the unfunded liabilities of Commonwealth defined benefit schemes. These liabilities have ballooned to an estimated $290 billion and taxpayers continue to be treated like fools.

Australia’s shameful super gap

ASFA provides a key guide for how much you will need to live on in retirement. Unfortunately it has many deficiencies, and the averages don't tell the full story of the growing gender superannuation gap.

Looking beyond banks for dividend income

The Big Four banks have had an extraordinary run and it’s left income investors with a conundrum: to stick with them even though they now offer relatively low dividend yields and limited growth prospects or to look elsewhere.

Latest Updates

Investment strategies

9 lessons from 2024

Key lessons include expensive stocks can always get more expensive, Bitcoin is our tulip mania, follow the smart money, the young are coming with pitchforks on housing, and the importance of staying invested.

Investment strategies

Time to announce the X-factor for 2024

What is the X-factor - the largely unexpected influence that wasn’t thought about when the year began but came from left field to have powerful effects on investment returns - for 2024? It's time to select the winner.

Shares

Australian shares struggle as 2020s reach halfway point

It’s halfway through the 2020s decade and time to get a scorecheck on the Australian stock market. The picture isn't pretty as Aussie shares are having a below-average decade so far, though history shows that all is not lost.

Shares

Is FOMO overruling investment basics?

Four years ago, we introduced our 'bubbles' chart to show how the market had become concentrated in one type of stock and one view of the future. This looks at what, if anything, has changed, and what it means for investors.

Shares

Is Medibank Private a bargain?

Regulatory tensions have weighed on Medibank's share price though it's unlikely that the government will step in and prop up private hospitals. This creates an opportunity to invest in Australia’s largest health insurer.

Shares

Negative correlations, positive allocations

A nascent theme today is that the inverse correlation between bonds and stocks has returned as inflation and economic growth moderate. This broadens the potential for risk-adjusted returns in multi-asset portfolios.

Retirement

The secret to a good retirement

An Australian anthropologist studying Japanese seniors has come to a counter-intuitive conclusion to what makes for a great retirement: she suggests the seeds may be found in how we approach our working years.

Sponsors

Alliances

© 2024 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.